-
-
(4S)-4-Tert-butyl-2-[1-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopropyl]-4,5-dihydro-1,3-oxazole,98%, 50mg
-
(4S)-4-Tert-butyl-2-[1-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopropyl]-4,5-dihydro-1,3-oxazole,98%, 10mg
-
(4R,4’R)-2,2′-Cyclopropylidenebis[4,5-dihydro-4-
phenyloxazole],98%, 250mg
-
(4R,4’R)-2,2′-Cyclopropylidenebis[4,5-dihydro-4-
phenyloxazole],98%, 50mg
-
(4R,4’R)-2,2′-Cyclopropylidenebis[4,5-dihydro-4-
phenyloxazole],98%, 10mg
-
(η5-2,4-Cyclopentadien-1-yl)[(5a,6,7,8,8a-η)-(5aS)-5-oxopentaleno[1,2-b]pyridin-5a(5H)-yl]iron,98%, 50mg
-
(η5-2,4-Cyclopentadien-1-yl)[(5a,6,7,8,8a-η)-(5aS)-5-oxopentaleno[1,2-b]pyridin-5a(5H)-yl]iron,98%, 10mg
-
1,1,1-Trifluoro-N-[(11bS)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-di
phenyl-dinaphtho[2,1-d:1’,2′-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide,98%, 250mg
-
1,1,1-Trifluoro-N-[(11bS)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-di
phenyl-dinaphtho[2,1-d:1’,2′-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide,98%, 50mg
-
1,1,1-Trifluoro-N-[(11bS)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-di
phenyl-dinaphtho[2,1-d:1’,2′-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide,98%, 10mg
-
S-VANOL hydrogenphosphate,98%, 50mg
стр.: